NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/04/2022
Back to search
Official data from USPTO
REHILGO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
11/04/2022
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
07/30/2020
Registration date
08/31/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/31/2021
Last transaction
08/31/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
DE
Examiner
CIANCI, RYAN MICHAEL
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CSL Behring GmbH
Representatives
Scott D. Woldow Smith, Gambrell & Russell, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for treating von Willebrand disease, hemophilia, primary immunodeficiency, hereditary angioedema, fibrinogen deficiency, Alpha 1 antitrypsin deficiency, and inflammatory demyelinating polyneuropathy; blood plasma; blood plasma fractions; recombinant protein arrays for medical diagnosis purposes; Pharmaceutical preparations for the treatment and prevention of blood and bleeding disorders; blood products for the treatment of hemophilia, namely, pharmaceutical preparations for the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment of hemophilia, namely, pharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia; blood products for the treatment of hemophilia, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations and substances for the treatment of blood disorders; antibodies, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; blood for medical purposes; cell cultures for medical purposes, namely, cells for medical or clinical use; cell cultures for medical purposes, namely, living cells for medical use; cell cultures for medical purposes, namely, stem cells for medical or veterinary use; pharmaceutical preparations for the treatment of blood conditions, respiratory conditions, pneumonia, covid-19, and influenza
Publications
History of USPTO decisions and trademark events.
22 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/27/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/07/2022
FIMP
FINAL DISPOSITION PROCESSED
02/07/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/30/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/31/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/15/2021
PUBO
PUBLISHED FOR OPPOSITION
06/15/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/26/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/11/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/11/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/11/2021
RFNT
REFUSAL PROCESSED BY IB
12/20/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/03/2020
RFRR
REFUSAL PROCESSED BY MPU
12/03/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/17/2020
CNRT
NON-FINAL ACTION WRITTEN
11/16/2020
DOCK
ASSIGNED TO EXAMINER
11/11/2020
MAFR
APPLICATION FILING RECEIPT MAILED
10/02/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/28/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/24/2020
Continuous trademark protection
Get notified about every new filing that threatens REHILGO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.